Study of the Impact of Trans Fatty Acids From Dairy Products on Cardiovascular Risk Factors
NCT ID: NCT01163175
Last Updated: 2011-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2006-05-31
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The general objective of the study is to investigate the impact of naturally occurring trans fatty acids from dairy products (mainly vaccenic acid) on plasma cholesterol levels and other risk factors for cardiovascular disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ruminant Trans Fats and the Risk of Cardiovascular Disease in Women
NCT00930137
Trans Fatty Acids and Cardiovascular Risk Factors
NCT00439582
Study of the Impact of Dairy Fat on Cardiovascular Health.
NCT02106208
Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease
NCT00942656
Impact of Vaccenic Acid Consumption on the Metabolism of Saturated Fatty Acids: Relationship With Cardiovascular Risk Factors
NCT00685581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ruminant trans fats
Consumption of the 4 experimental diets:
1. a diet rich in ruminant TFA (8 g/day);
2. a diet moderately rich in ruminant TFA (4 g/day);
3. a diet rich in industrial TFA (8 g/d);
4. a control diet (minimal dietary TFA of industrial and ruminant sources).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LDL-Cholesterol concentration \<3.4 mmol/L
* Stable body weight (+/- 2 kg) for 6 months before the beginning of the study
* Smoking or not
Exclusion Criteria
* Subjects taking medications for hyperlipidemia or hypertension
* Endocrine disorders
* Body mass index \> 30 kg/m2
* Food allergies
* Men with extreme nutritional habits such as vegetarism or alcohol consumption \> 2 drinks/day
* Elite athletes
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dairy Farmers of Canada
OTHER
Novalait Inc
UNKNOWN
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Institute of Nutraceutical and Functional Foods (INAF), Laval University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoît Lamarche, PhD
Role: PRINCIPAL_INVESTIGATOR
Laval University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Nutraceutical and Functional Foods (INAF), Laval University
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INAF-2005-233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.